CU Anschutz Cancer Center Expert Highlights Promise of ‘Miracle Drug’ in Ben Sasse’s Cancer Fight

A CU Anschutz Cancer Center oncologist, Chris Lieu, MD,  highlights the promise of the KRAS-targeting drug daraxonrasib as Ben Sasse reports major tumor reduction and extended survival.